{"id":"tp-32817","type":"article-newspaper","title":"Lilly’s Omvoh Shows 27.7% Disease Control Among Ulcerative Colitis Responders","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/32817","datePublished":"2026-10-15T22:20:37.000Z","dateModified":"2026-10-15T22:20:37.000Z","language":"en","abstract":"In a separate Crohn’s disease analysis, 20.4% of patients on Omvoh achieved corticosteroid-free deep remission, compared with 2% on placebo.","section":"Business","references":[]}